ODDB.org: Open Drug Database

Medius AG - Abevmy 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	70261	Sequence	02
Product name	Abevmy 400 mg/16 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FG01	ATC-Description	Bevacizumab
Introduction of Sequence	03.11.2025

Composition

bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, polysorbatum 20, natrii hydroxidum ad pH, acidum phosphoricum ad pH, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 17.9 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	400mg / 16ml

BAG: Active Agent	Dose
Bevacizumab	400 mg

Inactive agents
Acidum Phosphoricum ad Ph
Disodium Phosphate
Sodium Dihydrogenophosphate Dihydrate
Natrii Hydroxidum ad Ph
Polysorbatum 20
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		827.41	924.60	A	SL	No

2026	©ywesee GmbH